Healthcare

ANTARES VISION GROUP SIGNS STRATEGIC AGREEMENT WITH THE MEDICINES CONTROL AGENCY OF THE GAMBIA

BRESCIA, Italy, Sept. 11, 2025, 06:00 GMT-04

Antares-Agreement

Read full article →

Inpharmus Becomes a Leader in Rare Diseases and Oncology in the MERAT

ISTANBUL, Sept. 11, 2025, 04:27 GMT-04

INPHARMUS-MERAT

Read full article →

TROP2-Targeted Antibody-Drug Conjugates Set to Transform NSCLC Treatment Market by 2040 | DelveInsight

LAS VEGAS, Sept. 10, 2025, 17:31 GMT-04

DELVEINSIGHT-BUSINESS

Read full article →

TVM Capital Healthcare Announces First Closing of its USD 150 Million Southeast Asia Fund

SINGAPORE, Sept. 10, 2025, 14:34 GMT-04

TVM-Capital-Closing

Read full article →

Home Healthcare Market worth US$473.8 billion by 2030 with 8.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 10, 2025, 11:00 GMT-04

MARKETSANDMARKETS

Read full article →

Endoscope Reprocessing Market worth US$4.24 billion by 2030 with 9.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 10, 2025, 10:15 GMT-04

MARKETSANDMARKETS

Read full article →

Precision BioLogic Leads the Way in Hemophilia Testing

HALIFAX, NS, Sept. 10, 2025, 09:00 GMT-04

Precision-BioLogic

Read full article →

Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform

NAPLES, Fla., Sept. 10, 2025, 08:48 GMT-04

LUPIN-FDA-APPROVAL

Read full article →

Croma-Pharma GmbH Celebrates FDA Approval of Obagi saypha® MagIQ™ in the United States

LONDON, Sept. 10, 2025, 06:45 GMT-04

Croma-Pharma

Read full article →

FDA Accepts Biologics License Application for Sobi's NASP for Patients with Uncontrolled Gout

STOCKHOLM, Sept. 10, 2025, 02:54 GMT-04

SOBI

Read full article →

Implantica ramps-up production with 10,000 RefluxStop® units in preparation for U.S. launch, pending FDA PMA approval

VADUZ, Liechtenstein, Sept. 10, 2025, 02:14 GMT-04

Implantica

Read full article →

Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight

LAS VEGAS, Sept. 9, 2025, 17:31 GMT-04

DELVEINSIGHT

Read full article →

Autoinjectors Market Size will hit US$ 39.84 Billion by 2033, Driven by Patient-Centered Drug Delivery and Digital Innovation | DataM Intelligence

AUSTIN, Texas and TOKYO, Sept. 9, 2025, 13:17 GMT-04

DataM-Intelligence

Read full article →

Turacoz Unveils Its New Logo: A Bold Leap into Infinite Possibilities

UTRECHT, Netherlands, Sept. 9, 2025, 13:05 GMT-04

Turacoz-Healthcare

Read full article →

Molecular Diagnostics Market worth US$30.74 billion by 2030 with 9.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 9, 2025, 10:45 GMT-04

MarketsandMarkets

Read full article →

Lateral Flow Assays Market Size will Hit US$ 15.68 Billion by 2033, Driven by Infectious Disease Testing and AI-Powered Diagnostics | DataM Intelligence

AUSTIN, Texas and TOKYO, Sept. 9, 2025, 10:30 GMT-04

DATAM-INTELLIGENCE

Read full article →

Wearable Injectors Market worth US$18.91 billion by 2030 with 10.8% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 9, 2025, 10:15 GMT-04

MarketsandMarkets

Read full article →

Next Generation Antibody Therapeutics Market Size will Hit $22.88 Billion by 2033, Fueled by Breakthroughs in Oncology and AI-Driven Drug Design | DataM Intelligence

AUSTIN, Texas and TOKYO, Sept. 9, 2025, 10:01 GMT-04

DATAM

Read full article →

Inizio appoints Ryan Quigley as its new Chief Executive Officer to lead its next phase of growth

LONDON, Sept. 9, 2025, 09:00 GMT-04

INIZIO-new-CEO

Read full article →

Neurolief Announces Publication of Groundbreaking MOOD Study Demonstrating Efficacy of Home or Clinic-Based Neuromodulation Therapy for Major Depressive Disorder

CORAL SPRINGS, Fla., Sept. 9, 2025, 09:29 GMT-04

Neurolief

Read full article →